PNT - POINT Biopharma Global Inc
IEX Last Trade
12.51
12.510 100.000%
Share volume: 0
Last Updated: Tue 26 Dec 2023 09:07:44 PM CET
Pharmaceutical Preparation Manufacturing :
2.74%
PREVIOUS CLOSE
CHG
CHG%
N/A
0.00
0.00%
View ratios
Fiscal Date | 2023-03-31 | 2023-06-30 | 2024-09-30 | |
---|---|---|---|---|
Fiscal Quarter | Q1 2023 | Q2 2023 | Q3 2024 | |
Report Date | 2023-05-15 | 2023-08-14 | 2024-10-22 | |
Total revenue | 9.457 M | 4.866 M | 993.400 M | |
Cost of revenue | 0.000 | 0.000 | 600.200 M | |
Gross profit | 9.457 M | 4.866 M | 393.200 M | |
-48.55% | 7,980.80% | |||
Operating expenses | 31.921 M | 36.365 M | 213.300 M | |
Selling general and admin | 5.010 M | 5.088 M | 190.400 M | |
Research and development | 26.910 M | 31.277 M | 22.900 M | |
Total expenses | 31.921 M | 36.365 M | 213.300 M | |
13.92% | 486.55% | |||
Operating income | -22.463 M | -31.499 M | 179.900 M | |
Ebit | -22.463 M | -31.499 M | 180.000 M | |
Pretax income | -16.769 M | -26.332 M | 160.200 M | |
57.03% | -708.38% | |||
Income tax | -238.642 K | -921.298 K | 20.600 M | |
Net income basic | -16.531 M | -25.411 M | 0.000 | |
-53.72% | 100.00% | |||
Net income | -16.531 M | -25.411 M | 139.600 M | |
-53.72% | 649.37% |